First-line therapy for COPD exacerbation includes:

Prepare for the Rosh Internal Medicine Exam with quizzes, flashcards, and multiple-choice questions, complete with hints and explanations. Get ready to excel on your exam!

Multiple Choice

First-line therapy for COPD exacerbation includes:

Explanation:
In COPD exacerbations, the priority is to rapidly relieve airway obstruction and reduce airway inflammation. The best first-line approach combines systemic corticosteroids to dampen inflammation and shorten recovery with short-acting bronchodilators to quickly open the airways and improve breathing. This pair directly targets the two main problems of an acute flare: bronchoconstriction and airway inflammation. Oxygen therapy is important if the patient is hypoxemic, but it’s not a stand-alone treatment for the flare. Antibiotics are added if there are signs of a bacterial infection or increased sputum purulence, but they’re not used universally as first-line therapy. Inhaled corticosteroids alone don’t provide the rapid relief needed for an acute episode, and antibiotics alone don’t address bronchospasm or inflammation.

In COPD exacerbations, the priority is to rapidly relieve airway obstruction and reduce airway inflammation. The best first-line approach combines systemic corticosteroids to dampen inflammation and shorten recovery with short-acting bronchodilators to quickly open the airways and improve breathing. This pair directly targets the two main problems of an acute flare: bronchoconstriction and airway inflammation.

Oxygen therapy is important if the patient is hypoxemic, but it’s not a stand-alone treatment for the flare. Antibiotics are added if there are signs of a bacterial infection or increased sputum purulence, but they’re not used universally as first-line therapy. Inhaled corticosteroids alone don’t provide the rapid relief needed for an acute episode, and antibiotics alone don’t address bronchospasm or inflammation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy